Tudor Investment Corp’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-110,121
Closed -$465K 1743
2022
Q3
$465K Buy
110,121
+66,115
+150% +$279K 0.01% 1133
2022
Q2
$123K Sell
44,006
-62,647
-59% -$175K ﹤0.01% 1435
2022
Q1
$610K Sell
106,653
-88,221
-45% -$505K 0.01% 1030
2021
Q4
$1.78M Buy
+194,874
New +$1.78M 0.03% 643
2021
Q2
Sell
-51,690
Closed -$838K 1622
2021
Q1
$838K Buy
+51,690
New +$838K 0.02% 912
2020
Q3
Sell
-84,039
Closed -$1.24M 1390
2020
Q2
$1.24M Buy
+84,039
New +$1.24M 0.06% 408
2018
Q1
Sell
-81,951
Closed -$1.48M 1076
2017
Q4
$1.48M Buy
81,951
+61,309
+297% +$1.11M 0.04% 239
2017
Q3
$333K Buy
20,642
+2,024
+11% +$32.7K 0.01% 779
2017
Q2
$258K Buy
18,618
+1,724
+10% +$23.9K 0.01% 794
2017
Q1
$253K Buy
+16,894
New +$253K 0.01% 1096
2016
Q2
Sell
-19,943
Closed -$379K 1550
2016
Q1
$379K Buy
+19,943
New +$379K 0.01% 933
2015
Q4
Sell
-26,533
Closed -$647K 1578
2015
Q3
$647K Buy
26,533
+7,561
+40% +$184K 0.02% 563
2015
Q2
$591K Buy
+18,972
New +$591K 0.02% 637
2014
Q3
Sell
-40,800
Closed -$503K 1396
2014
Q2
$503K Buy
40,800
+15,801
+63% +$195K 0.02% 523
2014
Q1
$348K Buy
+24,999
New +$348K 0.01% 708